Literature DB >> 30071241

Liver transplantation in patients with multiple organ failures: Feasibility and outcomes.

Paul J Thuluvath1, Avesh J Thuluvath2, Steven Hanish3, Yulia Savva4.   

Abstract

BACKGROUND & AIMS: Multiple organ failures (OFs) are common in patients with cirrhosis, but the independent effect of the number or type of OFs on liver transplantation (LT) outcomes is not well defined.
METHOD: United Network for Organ Sharing data were analyzed from 2002 to 2016 for all adults listed for LT who received an LT within 30 days after listing. We estimated post-LT survival stratified by number and type of pre-transplant OFs before and after adjusting for confounding variables.
RESULTS: During the study period, 4,714 (4.1%) patients died and 19,375 (16.6%) patients were transplanted within 30 days of listing. One or more OF were more common in those who were transplanted (57.4%) compared to those without LT (9.5%). The probability of staying alive more than 30 days on the waiting list without LT decreased with increasing number of OFs; while 90% were alive without OF, only 20% were alive with two OFs, and 2-8% with three or more OFs. The interval between listing and transplantation decreased with an increase in OFs, and the median time to transplant after listing was only 4-5 days with three or more OFs. Although the risk of post-LT mortality increased with increasing number of OFs, the 90-day patient survival was 90% and one-year survival was 81% in the presence of 5-6 OFs. The number of OFs was an independent predictor of survival, but the maximum difference in one-year graft or patient survival between those without OF and those with 5-6 OFs was only 9%. Additionally, the type of OF had minimal impact on outcomes.
CONCLUSIONS: Liver transplantation is feasible with excellent outcomes, even in the presence of five or six OFs. LAY
SUMMARY: Multiple organ failures, ranging from 1-6, are common in hospitalized patients with cirrhosis. The survival without liver transplant is dismal in the presence of three or more organ failures. Small retrospective studies have shown that liver transplant is feasible with good outcomes even in the presence of multiple organ failures. In this study, using a large national dataset, we show that survival chances for more than 30 days in those with three or more organ failures are less than 8%. However, if a liver transplant is performed quickly, the survival chances are very high with one-year survival ranging from 84% with three organ failures to 81% with 5-6 organ failures.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liver transplant; Organ failure; Survival outcomes

Mesh:

Year:  2018        PMID: 30071241     DOI: 10.1016/j.jhep.2018.07.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

Review 1.  Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis.

Authors:  Iliana Doycheva; Paul J Thuluvath
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 2.  Transplantation for Acute-on-Chronic Liver Failure.

Authors:  Tiffany Wu; Vinay Sundaram
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-11-06

Review 3.  Acute-on-Chronic Liver Failure: A Distinct Clinical Syndrome That Has Reclassified Cirrhosis.

Authors:  Giovanni Perricone; Rajiv Jalan
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-12-20

Review 4.  Surgical Considerations Regarding Transplantation for the Patient With Acute-on-Chronic Liver Failure.

Authors:  Sobia Nasir Laique; Bijan Eghtesad; Christina C Lindenmeyer
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-28

Review 5.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10

Review 6.  Alcohol and Acute-on-Chronic Liver Failure.

Authors:  Maria Pilar Ballester; Richard Sittner; Rajiv Jalan
Journal:  J Clin Exp Hepatol       Date:  2021-12-22

Review 7.  Pretransplant management of the patient with severe acute-on-chronic liver failure.

Authors:  Bhupinder Kaur; Andres Cardenas; Constantine J Karvellas
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-05-26

8.  A nomogram to predict survival in patients with acute-on-chronic hepatitis B liver failure after liver transplantation.

Authors:  Liang Chen; Jiebin Zhang; Tongyu Lu; Jianye Cai; Jun Zheng; Jia Yao; Shuhong Yi; Hua Li; Guihua Chen; Hui Zhao; Yingcai Zhang; Yang Yang
Journal:  Ann Transl Med       Date:  2021-04

9.  'First week' is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure.

Authors:  Ashok Choudhury; Rajan Vijayaraghavan; Rakhi Maiwall; Manoj Kumar; Zhongping Duan; Chen Yu; Saeed Sadiq Hamid; Wasim Jafri; Amna Subhan Butt; Harshad Devarbhavi; Qin Ning; Ke Ma; Soek-Siam Tan; Akash Shukla; Radhakrishna Dhiman; Ajay Duseja; Sunil Taneja; C E Eapen; Ashish Goel; Sombat Treeprasertsuk; Mamun Al-Mahtab; Hasmik Ghazinyan; Dong Joon Kim; Manoj K Sahu; Guan Huei Lee; Laurentius A Lesmana; Rinaldi Cosmas Lesmana; Samir Shah; Zaigham Abbas; Jose D Sollano; P N Rao; Anand Kulkarni; Gamal Shiha; Ananta Shrestha; AKadir Dokmeci; Man Fung Yuen; Diana Alcantara Payawal; Kemal Fariz Kalista; V G Mohan Prasad; George K Lau; Fazal Karim; Priyanka Jain; Guresh Kumar; Vinod Arora; Viniyendra Pamecha; Piyush Sinha; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-10-04       Impact factor: 6.047

10.  Early Transplantation in Acute on Chronic Liver Failure: Who and When.

Authors:  Nadim Mahmud; Ruben Hernaez; Tiffany Wu; Vinay Sundaram
Journal:  Curr Hepatol Rep       Date:  2020-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.